Related Experiment Video
Updated: Dec 20, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Methodologic considerations in randomized clinical trials in reproductive medicine
Christos Venetis1, Thomas d'Hooghe2, Kurt T Barnhart3
1Centre for Big Data Research in Health, University of New South Wales Medicine, New South Wales, Australia; School of Women's and Children's Health, University of New South Wales Medicine, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia.
Randomized controlled trials (RCTs) are crucial for evidence-based medicine. This paper explores methodological issues, including different RCT types, interpretations, and their use in personalized medicine and big data comparisons.
Area of Science:
- Reproductive Medicine
- Clinical Trials Methodology
Background:
- Randomized controlled trials (RCTs) are fundamental to evidence-based medicine.
- This series discusses various aspects of RCTs, focusing here on methodological considerations.
Purpose of the Study:
- To explore methodologic issues in designing and interpreting randomized controlled trials.
- To discuss the application of RCTs in personalized medicine and for diagnostic/prognostic questions.
- To compare the utility of RCTs with big data approaches.
Main Methods:
- Discussion of different types of RCTs based on null hypothesis testing (superiority, noninferiority, equivalence).
- Comparison of frequentist and Bayesian statistical interpretations.
- Consideration of RCTs in the context of personalized medicine, diagnostics, and prognostics.
- Comparative analysis of RCTs versus big data.
Main Results:
- Different RCT designs address specific research questions and statistical interpretations.
- RCTs are adaptable to personalized medicine and can address diagnostic/prognostic inquiries.
- Big data offers complementary insights but does not replace RCTs.
Conclusions:
- Understanding methodologic nuances is key for effective RCT design and interpretation.
- RCTs remain vital tools, evolving with personalized medicine and big data analytics.
- The choice between RCTs and big data depends on the specific research question.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:46Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Regression Toward the Mean
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs